Directorate Change

Tate & Lyle PLC TATE & LYLE BOARD CHANGE Tate & Lyle PLC announces that Kai Nargolwala has decided to step down as a Non-Executive Director with effect from 31 December 2007. Mr Nargolwala is based in Singapore and, as previously announced, will be joining the Credit Suisse Group as Chief Executive Officer of the Asia-Pacific Region on 1 January 2008. The requirements of this new executive role mean that he will no longer be able to commit the required time to travel to the UK on a regular basis to attend Tate & Lyle Board meetings. This has prompted his decision to step down. Sir David Lees, Chairman of Tate & Lyle, said: 'I am very sorry that Kai's new work commitments make it necessary for him to step down from the Board. We thank him for his excellent contribution over the past three years and wish him every success in the future.' Kai Nargolwala said, 'I am disappointed that the time commitments of my new executive role mean I have to step down from the Board. I greatly enjoyed my time with Tate & Lyle and wish the Company every success in the future'. obile: 07798 837317 About Tate & Lyle: Tate & Lyle is a world leading manufacturer of renewable food and industrial ingredients. It uses innovative technology to transform corn and sugar into value-added ingredients for customers in the food, beverage, pharmaceutical, cosmetic, paper, packaging and building industries. The Company is a leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients, and citric acid. Tate & Lyle is the world number-one in industrial starches and is the sole manufacturer of SPLENDA(R) Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company operates more than 50 production facilities throughout Europe, the Americas and South East Asia. In the year to 31 March 2007, it employed 6,900 people in its subsidiaries with a further 2,300 employed in joint ventures. Sales in the year to 31 March 2007 totalled £4.0 billion. Additional information can be found on http://www.tateandlyle.com. SPLENDA(R) is a trademark of McNeil Nutritionals, LLC

Companies

Tate & Lyle (TATE)
UK 100

Latest directors dealings